• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

I Ahrens, GYH Lip, K Peter

Thrombosis and Haemostasis | GEORG THIEME VERLAG KG | Published : 2011

DOI: 10.1160/TH10-12-0808

University of Melbourne Researchers

Karlheinz Peter's Profile Picture
Karlheinz Peter Author

Citation metrics

68Scopus
54Web of Science
60Dimensions

Keywords

Prevention
3201 Cardiovascular Medicine and Haematology
Peripheral Vascular Disease
Science & Technology
Hematology
Heart Disease
Clinical Research
Cerebrovascular
Inhibitor
Neurosciences
Life Sciences & Biomedicine
Warfarin
32 Biomedical and Clinical Sciences
Clinical Trials and Supportive Activities
Cardiovascular
Apixaban
Brain Disorders
Rationale
Cardiovascular System & Cardiology
Safety
Efficacy
Design
3202 Clinical Sciences

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224